Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: ROP stock price vs A: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at A's multiple
Needs A P/E.
Implied fair value · at ROP's multiple
Needs ROP P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Eight period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
ROPER TECHNOLOGIES, INC. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
AGILENT TECHNOLOGIES, INC. · implied price per share
Bear
$41.49
Base
$49.80
Bull
$60.61
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
HONEYWELL INTERNATIONAL INC
ROP vs HON
EMERSON ELECTRIC CO
ROP vs EMR
Fortive Corp
ROP vs FTV
Keysight Technologies, Inc.
ROP vs KEYS
METTLER TOLEDO INTERNATIONAL INC/
ROP vs MTD
Vontier Corp
ROP vs VNT
THERMO FISHER SCIENTIFIC INC.
ROP vs TMO
ILLUMINA, INC.
ROP vs ILMN
BIO-TECHNE Corp
ROP vs TECH
BRUKER CORP
ROP vs BRKR
Azenta, Inc.
ROP vs AZTA
WATERS CORP /DE/
ROP vs WAT
Edwyn research
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe ROP can sustain its faster growth and superior margins without deleveraging pressure, then hold or modestly add because the stock still offers about 9.7% upside to the P/E-implied value and trades below A-implied range; otherwise, the weaker ROIC and higher net debt/EBITDA argue for patience.
ROP trades at $391.97 versus a P/E-implied value of $429.95, implying 9.7% upside, so the stock is not deeply discounted on this framework. The valuation case is tempered by the fact that ROP already trades below A-implied range midpoint and above the low end of its historical band, suggesting fair-to-slightly undervalued rather than clearly cheap.
Supporting Metrics
